UnitedHealth Group Incorporated

UnitedHealth shares are trading near the lower half of their 52-week range after the company reported a 32.7% drop in EPS year-over-year, even as revenue grew 6.5%. Net margin has compressed to 3.1%, reflecting higher medical costs and regulatory headwinds in the Medicare Advantage business. The stock's P/E of 23.57 sits below the sector median, but the Alpha Score of 36.1 points to weak momentum and value scores (36.5) that have yet to attract bargain hunters. Quality at 35.8 suggests the earnings deterioration is structural rather than cyclical. Sentiment at 50 is neutral. The Roundhill UNH WeeklyPay ETF's 38.9% yield and GF Value's 36% discount signal that income-focused investors see a floor, but the fundamental story remains under pressure until margins stabilize. Next week's managed care sector data will test whether utilization trends are easing.

UnitedHealth shares remain well off their 52-week high of $461.62 after earnings per share slid 32.7% year-over-year, despite revenue growing 6.5% to push net margins to 3.1%. The stock trades at a P/E of 23.57, with an Alpha Score of 36.1 — a sub-40 reading that reflects split signals: value scores at 36.5 and quality at 35.8, while sentiment sits at an elevated 50. Momentum is neutral, carrying no directional signal. The Roundhill UNH WeeklyPay ETF yields 38.9% with a 49% payout ratio, while GF Value marks a 36% discount to fair value. Next week's focus: any commentary on medical cost trends or membership growth from management at upcoming industry conferences.

UnitedHealth Group shares trade at 25.6 times earnings, with a net margin of just 3.1%. Revenue rose 6.5% from a year ago, but earnings per share fell 32.7% — a sharp compression that leaves the company well below its 52-week high of $461.62. The Alpha Score of 35.7 reflects weak momentum and modest value and quality scores near 35-36, while sentiment sits at 50. GF Value data points to a 36% discount to fair value, though the EPS decline suggests margin pressure persists. Watch for the next quarterly update, expected in mid-July, for signs of whether cost trends are stabilizing.

UnitedHealth trades near $398, roughly 14% below the $461.62 high and more than 50% above the $255.97 low of the past 52 weeks. That puts the stock above the midpoint of that range. The 25.63 trailing P/E on EPS of $15.55 comes as revenue growth holds at 6.5% while EPS growth turns negative at -32.7%, leaving net margin at 3.1%. The Alpha Score of 35.7 splits unevenly: quality at 35.9, value at 35.2, sentiment at 50, momentum null. A null momentum reading means price trend contributes nothing to the overall score. A GF Value screen recently flagged a 36% discount to fair value. The Roundhill UNH WeeklyPay ETF, a covered-call structure on UNH shares, yields 38.9% with a 49% payout ratio; that income stems from options premiums, not the stock's dividend. The ETF metrics reflect the options strategy, not a change in UnitedHealth's finances. The next quarterly report will test whether the earnings slide is stabilizing.

UnitedHealth Group fell as the company reported a 32.7% decline in EPS from a year ago, with net margins shrinking to 3.1%. Revenue grew 6.5%, but rising medical costs ate into profitability. The stock now trades at 25.6 times earnings, below its five-year average. UNH shares sit near the lower end of their 52-week range, about 32% below the January high of $461.62. The Alpha Score of 35.7 reflects weak momentum and middling value and quality scores; sentiment at 50 sits exactly neutral. Investors will watch next quarter's medical cost ratio for signs of stabilization in the commercial and Medicare Advantage segments.